P16 Immunostaining Patterns in Microglandular Hyperplasia of the Cervix and Their Significance

P16 immunostaining is an important adjunct in the differential diagnosis of difficult squamous and glandular intraepithelial lesions of the cervix. However, unexpected staining of epithelium other than the target lesion can pose a problem in the interpretation. This study examined a common entity in the cervix, microglandular hyperplasia (MGH), that is associated with proliferations of both columnar and squamous epithelial cells—and ascertained the frequency of p16 staining, its pattern, and relationship to human papillomavirus. Fifty-seven cases of MGH were analyzed; 25 scored strongly immunopositive (44%). In 18, staining of the superficial columnar epithelium was patchy, involving 10% to 20% of cells on the surface; in 4 cases, 30% to 40% of cells; and in another 3, over 50% of the cells in a given area were strongly positive. Staining involved both nucleus and cytoplasm of columnar cells. P16 positivity did not colocalize with either cyclin E or MIB-1. Adjacent non–MGH-related columnar epithelium scored negative for p16. Of 25 p16-positive columnar epithelia analyzed, all were human papillomavirus -negative. In conclusion, benign columnar epithelium in the setting of MGH can be expected to stain strongly for p16. Practitioners should be aware of this when evaluating diagnostically difficult squamous or glandular epithelial changes occurring in the setting of MGH or when interpreting cytologic preparations stained with p16.

[1]  M. Lindh,et al.  Are adjunctive markers useful in routine cervical cancer screening? Application of p16INK4a and HPV‐PCR on ThinPrep samples with histological follow‐up , 2008, Diagnostic cytopathology.

[2]  N. Boehm,et al.  P16 expression in relation to human papillomavirus in liquid-based cervical smears. , 2008, Gynecologic oncology.

[3]  A. Nassar,et al.  Comparison of p16INK4A and Hybrid Capture® 2 human papillomavirus testing as adjunctive tests in liquid‐based gynecologic SurePath™ preparations , 2008, Diagnostic cytopathology.

[4]  Lisa D. Duncan,et al.  Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance , 2008, Cancer.

[5]  T. Wise-Draper,et al.  Papillomavirus E6 and E7 proteins and their cellular targets. , 2008, Frontiers in bioscience : a journal and virtual library.

[6]  A. Ayhan,et al.  Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. , 2007, Pathology, research and practice.

[7]  P. V. van Diest,et al.  p16 is Consistently Expressed in Endometrial Tubal Metaplasia , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[8]  M. Troxell,et al.  p16INK4A Immunohistochemistry is Superior to HPV In Situ Hybridization for the Detection of High-risk HPV in Atypical Squamous Metaplasia , 2007, The American journal of surgical pathology.

[9]  H. Yee,et al.  Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the Differential Diagnosis of Benign, Premalignant, and Malignant Glandular Lesions of the Uterine Cervix and Their Relationship with Silverberg Scoring System for Endocervical Glandular Lesions , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[10]  T. Kondo,et al.  p16INK4a Overexpression Independent of Human Papillomavirus Infection in Lobular Endocervical Glandular Hyperplasia , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  W. McCluggage,et al.  Ectopic Prostatic Tissue in the Uterine Cervix and Vagina: Report of a Series With a Detailed Immunohistochemical Analysis , 2006, The American journal of surgical pathology.

[12]  J. Rheinwald,et al.  Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. , 2005, The journal of investigative dermatology. Symposium proceedings.

[13]  J. Sturmberg,et al.  Complexity and healthcare organization: a view from the street , 2005, International Journal of Integrated Care.

[14]  M. Spitzer,et al.  Differentiating High-Grade Cervical Intraepithelial Lesion from Atrophy in Postmenopausal Women Using Ki-67, Cyclin E, and p16 Immunohistochemical Analysis , 2005, Journal of lower genital tract disease.

[15]  F. McKeon,et al.  Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. , 2005, Human pathology.

[16]  C. Crum,et al.  Eosinophilic Dysplasia of the Cervix: A Newly Recognized Variant of Cervical Squamous Intraepithelial Neoplasia , 2004, American Journal of Surgical Pathology.

[17]  N. Kiviat,et al.  p16INK4a Expression Correlates with Degree of Cervical Neoplasia: A Comparison with Ki-67 Expression and Detection of High-Risk HPV Types , 2003, Modern Pathology.

[18]  M. Bibbo,et al.  P16INK4A as an adjunct test in liquid-based cytology. , 2003, Analytical and quantitative cytology and histology.

[19]  A. Haitel,et al.  p16INK4a Is a Useful Marker for the Diagnosis of Adenocarcinoma of the Cervix Uteri and Its Precursors: An Immunohistochemical Study With Immunocytochemical Correlations , 2003, The American journal of surgical pathology.

[20]  A. Saqi,et al.  Overexpression of p16INK4A in liquid‐based specimens (SurePath™) as marker of cervical dysplasia and neoplasia , 2002, Diagnostic cytopathology.

[21]  P. Maxwell,et al.  Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. , 2002, Histopathology.

[22]  S. Riethdorf,et al.  Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. , 2002, Human pathology.

[23]  B. Quade,et al.  Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia , 2001, The American journal of surgical pathology.

[24]  B. Quade,et al.  Expression of the p53 homologue p63 in early cervical neoplasia. , 2001, Gynecologic oncology.

[25]  F. McKeon,et al.  Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. , 2001, Gynecologic oncology.

[26]  F. McKeon,et al.  Stratified Mucin-Producing Intraepithelial Lesions of the Cervix: Adenosquamous or Columnar Cell Neoplasia? , 2000, The American journal of surgical pathology.

[27]  B. Quade,et al.  In vivo cyclin E expression as a marker for early cervical neoplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[28]  G. Lindberg,et al.  Ectopic prostatic tissue in the uterine cervix. , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[29]  S. Selvaggi,et al.  Microglandular endocervical hyperplasia and tubal metaplasia: Pitfalls in the diagnosis of adenocarcinoma on cervical smears , 1997, Diagnostic cytopathology.

[30]  S. Silverberg,et al.  Microglandular hyperplasia of the cervix: a true "pill" lesion? , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[31]  R. Scully,et al.  Uterine Carcinomas Simulating Microglandular Hyperplasia: A Report of Six Cases , 1992, The American journal of surgical pathology.

[32]  E. Chalas,et al.  Microglandular Hyperplasia of the Uterine Cervix , 1985, Obstetrics and gynecology.

[33]  D. Dufour,et al.  Pathogenesis of Microglandular Hyperplasia of the Cervix Uteri , 1976, Obstetrics and gynecology.